Role of Prion Protein in Manganese Neurotoxicity
朊病毒蛋白在锰神经毒性中的作用
基本信息
- 批准号:8912060
- 负责人:
- 金额:$ 4.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-09 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAnimal ModelAnimalsAntioxidantsApoptosisApoptoticAttenuatedBasal GangliaBindingBinding ProteinsBinding SitesBiological AssayBloodBovine Spongiform EncephalopathyBrainBrain DiseasesBrain regionCell AdhesionCell Adhesion MoleculesCell Culture TechniquesCell DeathCell physiologyCellsChronicChronic Wasting DiseaseCopperDataDeerDigestionDiseaseDivalent CationsDoseEndopeptidase KEnvironmental ExposureEtiologyExposure toFigs - dietaryGenetic TranscriptionHeat shock proteinsHomeostasisHumanInfectionInvestigationKnockout MiceLinkMammalsManganeseMetalloproteinsMetalsMitochondriaModelingMusNerve DegenerationNeurodegenerative DisordersNeurologicNeuronsOrganismOxidative StressPathogenesisPathologic ProcessesPeptide HydrolasesPlayPrPPrPSc ProteinsPrion DiseasesPrionsProtein RegionProteinsReportingResearchResistanceRoleScrapieSeedsSeveritiesSignal TransductionSliceStagingStressStructureTestingTimeTransducersTransgenic AnimalsTransgenic MiceTransgenic ModelTransition ElementsUp-RegulationZincconformational conversiondivalent metalinsightmitochondrial dysfunctionmouse modelmutantneurochemistryneurotoxicitynoveloverexpressionoxidative damageparticleprotein aggregationprotein functionprotein misfolding cyclic amplificationresponsestress protein
项目摘要
DESCRIPTION (provided by applicant): Environmental exposure to transition metals is linked to pathological processes of various neurodegenerative conditions since metal neurotoxicity often augments key degenerative changes including ionic imbalance, oxidative stress and protein aggregation. Several metal binding proteins regulate intracellular metal homeostasis and thereby maintain normal cellular function. Emerging evidence indicates that prion proteins are metal binding proteins that can efficiently bind to certain divalent cations including copper and manganese at the octapeptide repeat regions of the protein. Therefore, dysregulation of metal homeostasis has been suggested to play a role in the pathogenesis of prion diseases. Recent observations of elevated manganese (Mn) levels in the brain and blood of humans and animals afflicted with prion diseases suggest that manganese neurotoxicity may play a role in the etiology of prion diseases. Recently, we demonstrated that normal prion protein effectively attenuates manganese transport into neuronal cells and protects against manganese-induced oxidative stress, mitochondrial dysfunction, cellular antioxidant depletion, and apoptosis. While investigating these mechanisms, we unexpectedly found that manganese treatment upregulates cellular prion levels independent of transcription. Furthermore, we found manganese increases stability, suggesting that prion protein may promote the conversion of normal prion protein (PrPC) to the pathological form of prion (PrPSc), which results in the loss of normal prion protein's protective function against manganese neurotoxicity. Thus, the central hypothesis of this proposal is that manganese binds to the octapeptide (PHGGGWGQ) domain of cellular prion protein to increase the stability and accumulation of the protein. Manganese-induced stabilization of prion protein accelerates conformational conversion of PrPC to proteinase-resistant prion protein (PrPSc) aggregates and thereby induces neurotoxicity. This novel hypothesis will be tested through a systematic investigation of the following specific aims: i) to determine whether chronic exposure to manganese increases prion protein accumulation in animal models, ii) to determine the role of octapeptide repeat sequences in the manganese-induced stabilization of prion protein, iii) to determine whether chronic manganese exposure accelerates the accumulation and aggregation of the scrapie form of prion protein (PrPSc) and causes increased neuronal damage in a mouse model of prion disease, iv) to compare the effect of manganese on the accumulation and aggregation of PrPSc and on neuronal damage in mouse scrapie-infected prion overexpressing and octapeptide deletion transgenic animals (Tg20 and TgPrPDOR transgenic mice). Together, results from the proposed studies will not only provide new insights into the role of prion protein in manganese neurotoxicity but also will advance understanding of the role of metals in the pathogenesis of prion diseases.
描述(由申请人提供):过渡金属的环境暴露与各种神经退行性疾病的病理过程有关,因为金属神经毒性通常会增强关键的退行性变化,包括离子失衡、氧化应激和蛋白质聚集。几种金属结合蛋白调节细胞内金属稳态,从而维持正常的细胞功能。新出现的证据表明,朊病毒蛋白是金属结合蛋白,可以有效地结合到某些二价阳离子,包括铜和锰的八肽重复区的蛋白质。因此,金属稳态失调已被认为在朊病毒疾病的发病机制中发挥作用。最近观察到患有朊病毒疾病的人类和动物的脑和血液中锰(Mn)水平升高,表明锰神经毒性可能在朊病毒疾病的病因学中起作用。最近,我们证明,正常朊病毒蛋白有效地减弱锰转运到神经元细胞,并保护对锰诱导的氧化应激,线粒体功能障碍,细胞抗氧化剂消耗和细胞凋亡。在研究这些机制时,我们意外地发现锰处理上调细胞朊病毒水平,而不依赖于转录。此外,我们发现锰增加了朊蛋白的稳定性,这表明朊蛋白可能促进正常朊蛋白(PrPC)转化为朊蛋白(PrPSc)的病理形式,这导致正常朊蛋白对锰神经毒性的保护功能丧失。因此,该提议的中心假设是锰与细胞朊病毒蛋白的八肽(PHGGGWGQ)结构域结合以增加蛋白的稳定性和积累。锰诱导的朊病毒蛋白的稳定化加速了PrPC向蛋白酶抗性朊病毒蛋白(PrPSc)聚集体的构象转化,从而诱导神经毒性。这一新的假设将通过对以下具体目标的系统研究进行检验:i)确定慢性暴露于锰是否增加动物模型中朊病毒蛋白的积累,ii)确定八肽重复序列在锰诱导的朊病毒蛋白稳定化中的作用,iii)确定慢性锰暴露是否加速羊瘙痒症形式的朊病毒蛋白(PrPSc)的积累和聚集并在朊病毒病的小鼠模型中引起增加的神经元损伤,iv)比较锰对PrPSc的积累和聚集以及对小鼠羊瘙痒病感染的朊病毒过表达和八肽缺失转基因动物(Tg20和TgPrPDOR转基因小鼠)中神经元损伤的影响。总之,从拟议的研究结果不仅将提供新的见解朊病毒蛋白在锰神经毒性的作用,但也将推进金属的朊病毒疾病的发病机制中的作用的理解。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity.
- DOI:10.1126/sciadv.1600014
- 发表时间:2016-07
- 期刊:
- 影响因子:13.6
- 作者:Yen CF;Harischandra DS;Kanthasamy A;Sivasankar S
- 通讯作者:Sivasankar S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anumantha Gounder Kanthasamy其他文献
Anumantha Gounder Kanthasamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anumantha Gounder Kanthasamy', 18)}}的其他基金
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
基于微生物组的新型生物疗法可治疗阿尔茨海默病和相关痴呆症的认知和行为症状
- 批准号:
10527152 - 财政年份:2022
- 资助金额:
$ 4.89万 - 项目类别:
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
基于微生物组的新型生物疗法可治疗阿尔茨海默病和相关痴呆症的认知和行为症状
- 批准号:
10677787 - 财政年份:2022
- 资助金额:
$ 4.89万 - 项目类别:
Novel Re-engineered L DOPA Probiotic Therapy for Parkinson's Disease
新型重新设计的左旋多巴益生菌疗法治疗帕金森病
- 批准号:
10688149 - 财政年份:2021
- 资助金额:
$ 4.89万 - 项目类别:
Protein Aggregation and Inflammasome Signaling in Manganese Neurotoxicity.
锰神经毒性中的蛋白质聚集和炎症小体信号传导。
- 批准号:
10508354 - 财政年份:2021
- 资助金额:
$ 4.89万 - 项目类别:
Novel Re-engineered L DOPA probiotic therapy for Parkinsons Disease
新型重新设计的左旋多巴益生菌疗法治疗帕金森病
- 批准号:
10453379 - 财政年份:2021
- 资助金额:
$ 4.89万 - 项目类别:
Novel Re-engineered L DOPA Probiotic Therapy for Parkinson's Disease
新型重新设计的左旋多巴益生菌疗法治疗帕金森病
- 批准号:
10618744 - 财政年份:2021
- 资助金额:
$ 4.89万 - 项目类别:
Novel Re-engineered L DOPA probiotic therapy for Parkinsons Disease
新型重新设计的左旋多巴益生菌疗法治疗帕金森病
- 批准号:
10043372 - 财政年份:2020
- 资助金额:
$ 4.89万 - 项目类别:
Neuroinflammation and microglial Kv1.3 in Parkinsons disease
帕金森病中的神经炎症和小胶质细胞 Kv1.3
- 批准号:
10528896 - 财政年份:2017
- 资助金额:
$ 4.89万 - 项目类别:
Novel Mechanisms of Pesticide-Induced Neurotoxicity
农药引起的神经毒性的新机制
- 批准号:
9906057 - 财政年份:2017
- 资助金额:
$ 4.89万 - 项目类别:
Neuroinflammation and microglial Kv1.3 in Parkinsons disease
帕金森病中的神经炎症和小胶质细胞 Kv1.3
- 批准号:
9921502 - 财政年份:2017
- 资助金额:
$ 4.89万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 4.89万 - 项目类别:
Continuing Grant